These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9448028)

  • 41. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Development of an AIDS vaccine: status report].
    Girard MP
    Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New gene-based approaches for an AIDS vaccine.
    Puaux AL; Michel ML
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):357-72. PubMed ID: 12818622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AAP releases recommendations on use of inactivated and live oral polio vaccines. American Academy of Pediatrics.
    Morey SS
    Am Fam Physician; 1999 Jun; 59(11):3268. PubMed ID: 10392600
    [No Abstract]   [Full Text] [Related]  

  • 46. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
    Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antiviral vaccines].
    Girard M
    Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No AIDS risk from polio vaccines.
    Ann Pharmacother; 1992 Jun; 26(6):867. PubMed ID: 1611175
    [No Abstract]   [Full Text] [Related]  

  • 49. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
    Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
    Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polio vaccines and polioviruses.
    Br Med J; 1977 Jun; 1(6077):1617-8. PubMed ID: 194649
    [No Abstract]   [Full Text] [Related]  

  • 51. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immune effects of mutated hepatitis B virus precore-core DNA vaccines in mice].
    Zhang M; Xin SJ; Hu Y; Hou J; Shen HH; Wang ZJ; Mao PY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):446-8. PubMed ID: 19544641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 55. [The reactogenicity of Heberbiovac-HB vaccine at different doses].
    Díaz González M; Navia Molina O; Bravo González JR; Pedroso Flaquet P; Urbino López A
    Rev Cubana Med Trop; 1995; 47(1):65-70. PubMed ID: 9805071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
    Coupar BE; Purcell DF; Thomson SA; Ramshaw IA; Kent SJ; Boyle DB
    Vaccine; 2006 Feb; 24(9):1378-88. PubMed ID: 16257479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hazards of vaccine production.
    Beale AJ
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):469-73. PubMed ID: 1478477
    [No Abstract]   [Full Text] [Related]  

  • 59. Shock horror! Nurses rush for jabs to guard against AIDS.
    Nurs Times; 1989 Nov 8-14; 85(45):24. PubMed ID: 2531861
    [No Abstract]   [Full Text] [Related]  

  • 60. [Genetic determinants of neurovirulence and attenuation of poliovirus].
    Azol VI
    Mol Gen Mikrobiol Virusol; 1988 Jan; (1):3-9. PubMed ID: 2833691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.